These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 9682005)
1. Regulatory role of T cells in a murine model of lymphoproliferative disease. Raveche E; Fernandes H; Ong H; Peng B Cell Immunol; 1998 Jul; 187(1):67-75. PubMed ID: 9682005 [TBL] [Abstract][Full Text] [Related]
2. A cultured malignant B-1 line serves as a model for Richter's syndrome. Peng B; Sherr DH; Mahboudi F; Hardin J; Wu YH; Sharer L; Raveché ES J Immunol; 1994 Aug; 153(4):1869-80. PubMed ID: 8046247 [TBL] [Abstract][Full Text] [Related]
3. Vasculitis in the Palmerston North mouse model of lupus: phenotype and cytokine production profile of infiltrating cells. Luzina IG; Knitzer RH; Atamas SP; Gause WC; Papadimitriou JC; Sztein MB; Storrer CE; Handwerger BS Arthritis Rheum; 1999 Mar; 42(3):561-8. PubMed ID: 10088780 [TBL] [Abstract][Full Text] [Related]
4. The NZB mouse as a model for chronic lymphocytic leukemia. Phillips JA; Mehta K; Fernandez C; Raveché ES Cancer Res; 1992 Jan; 52(2):437-43. PubMed ID: 1370214 [TBL] [Abstract][Full Text] [Related]
5. Tissue-specific expansion of NKT and CD5+B cells at the onset of autoimmune disease in (NZBxNZW)F1 mice. Morshed SR; Mannoor K; Halder RC; Kawamura H; Bannai M; Sekikawa H; Watanabe H; Abo T Eur J Immunol; 2002 Sep; 32(9):2551-61. PubMed ID: 12207339 [TBL] [Abstract][Full Text] [Related]
6. Cell cycle effects of IL-10 on malignant B-1 cells. Yen Chong S; Lin YC; Czarneski J; Zhang M; Coffman F; Kashanchi F; Raveche E Genes Immun; 2001 Aug; 2(5):239-47. PubMed ID: 11528515 [TBL] [Abstract][Full Text] [Related]
7. Requirement for increased IL-10 in the development of B-1 lymphoproliferative disease in a murine model of CLL. Ramachandra S; Metcalf RA; Fredrickson T; Marti GE; Raveche E J Clin Invest; 1996 Oct; 98(8):1788-93. PubMed ID: 8878429 [TBL] [Abstract][Full Text] [Related]
8. Altered CD45 expression in malignant B-1 cells. Dang AM; Phillips JA; Lin T; Raveche ES Cell Immunol; 1996 May; 169(2):196-207. PubMed ID: 8620547 [TBL] [Abstract][Full Text] [Related]
9. Studies in NZB IL-10 knockout mice of the requirement of IL-10 for progression of B-cell lymphoma. Czarneski J; Lin YC; Chong S; McCarthy B; Fernandes H; Parker G; Mansour A; Huppi K; Marti GE; Raveche E Leukemia; 2004 Mar; 18(3):597-606. PubMed ID: 14712288 [TBL] [Abstract][Full Text] [Related]
10. In vivo effects of hyperdiploid Ly-1+ B cells of NZB origin. Raveche ES; Lalor P; Stall A; Conroy J J Immunol; 1988 Dec; 141(12):4133-9. PubMed ID: 3264305 [TBL] [Abstract][Full Text] [Related]
11. T cell cytokine imbalance towards production of IFN-gamma and IL-10 in NZB/W F1 lupus-prone mice is associated with autoantibody levels and nephritis. Enghard P; Langnickel D; Riemekasten G Scand J Rheumatol; 2006; 35(3):209-16. PubMed ID: 16766368 [TBL] [Abstract][Full Text] [Related]
12. Autologous T cells control B-chronic lymphocytic leukemia tumor progression in human-->mouse radiation chimera. Shimoni A; Marcus H; Dekel B; Shkarchi R; Arditti F; Shvidel L; Shtalrid M; Bucher W; Canaan A; Ergas D; Berrebi A; Reisner Y Cancer Res; 1999 Dec; 59(23):5968-74. PubMed ID: 10606243 [TBL] [Abstract][Full Text] [Related]
13. Unconventional NK1.1(-) intermediate TCR cells as major T lymphocytes expanding in chronic graft-versus-host disease. Miyakawa R; Miyaji C; Watanabe H; Yokoyama H; Tsukada C; Asakura H; Abo T Eur J Immunol; 2002 Sep; 32(9):2521-31. PubMed ID: 12207336 [TBL] [Abstract][Full Text] [Related]
14. The mechanism of nasal tolerance in lupus prone mice is T-cell anergy induced by immature B cells that lack B7 expression. Wu HY; Monsonego A; Weiner HL J Autoimmun; 2006 Mar; 26(2):116-26. PubMed ID: 16426816 [TBL] [Abstract][Full Text] [Related]
15. Leishmania amazonensis: participation of regulatory T and B cells in the in vitro priming (PIV) of CBA/J spleen cells susceptible response. Veras PS; Welby-Borges M; de Santana CD; Nihei J; Cardillo F; de Freitas LA Exp Parasitol; 2006 Jul; 113(3):201-5. PubMed ID: 16516200 [TBL] [Abstract][Full Text] [Related]
16. IL-4Ralpha polymorphism in regulation of IL-4 synthesis by T cells: implication in susceptibility to a subset of murine lupus. Shiroiwa W; Tsukamoto K; Ohtsuji M; Lin Q; Ida A; Kodera S; Ohtsuji N; Nakamura K; Tsurui H; Kinoshita K; Nishimura H; Shirai T; Hirose S Int Immunol; 2007 Feb; 19(2):175-83. PubMed ID: 17189592 [TBL] [Abstract][Full Text] [Related]
17. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction. Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399 [TBL] [Abstract][Full Text] [Related]
18. B cell apoptosis accelerates the onset of murine lupus. Trébéden-Nègre H; Weill B; Fournier C; Batteux F Eur J Immunol; 2003 Jun; 33(6):1603-12. PubMed ID: 12778478 [TBL] [Abstract][Full Text] [Related]
19. A transgenic model to analyze the immunoregulatory role of IL-10 secreted by antigen-presenting cells. Groux H; Cottrez F; Rouleau M; Mauze S; Antonenko S; Hurst S; McNeil T; Bigler M; Roncarolo MG; Coffman RL J Immunol; 1999 Feb; 162(3):1723-9. PubMed ID: 9973435 [TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor-induced chemotaxis and IL-10 from T cells. Shin JY; Yoon IH; Kim JS; Kim B; Park CG Cell Immunol; 2009; 256(1-2):72-8. PubMed ID: 19249018 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]